Simulations Plus IncNASDAQ:SLP
- LAST PRICE28.6900
- TODAY'S CHANGE (%)-1.0200 (-3.4332%)
- Bid / Lots28.6300/ 6
- Ask / Lots28.7500/ 6
- Open / Previous Close30.0800 / 29.7100
- Day Range
- 52 Week Range
- Volume108,637
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SLP |
|---|---|---|
| 09:32 ET | 7431 | 30.08 |
| 09:33 ET | 200 | 29.635 |
| 09:35 ET | 281 | 29.8089 |
| 09:37 ET | 600 | 29.46 |
| 09:39 ET | 468 | 29.5 |
| 09:42 ET | 100 | 29.495 |
| 09:44 ET | 658 | 29.42 |
| 09:46 ET | 893 | 29.335 |
| 09:48 ET | 200 | 29.46 |
| 09:53 ET | 300 | 29.33 |
| 09:55 ET | 1800 | 29.6 |
| 09:57 ET | 865 | 29.8 |
| 10:00 ET | 1318 | 29.91 |
| 10:02 ET | 500 | 29.91 |
| 10:04 ET | 3660 | 29.745 |
| 10:06 ET | 600 | 29.725 |
| 10:09 ET | 500 | 29.715 |
| 10:11 ET | 600 | 29.695 |
| 10:13 ET | 1948 | 29.605 |
| 10:15 ET | 2252 | 29.62 |
| 10:18 ET | 300 | 29.24 |
| 10:20 ET | 400 | 29.21 |
| 10:22 ET | 1700 | 29.13 |
| 10:24 ET | 100 | 29.18 |
| 10:29 ET | 100 | 29.1 |
| 10:31 ET | 300 | 28.93 |
| 10:33 ET | 795 | 29.07 |
| 10:36 ET | 125 | 28.982 |
| 10:38 ET | 100 | 29.025 |
| 10:42 ET | 221 | 29.103 |
| 10:44 ET | 100 | 29.025 |
| 10:45 ET | 100 | 29.1 |
| 10:47 ET | 100 | 29.08 |
| 10:49 ET | 300 | 29.14 |
| 10:51 ET | 1300 | 29.15 |
| 10:54 ET | 100 | 29.15 |
| 10:56 ET | 300 | 29 |
| 11:00 ET | 100 | 28.875 |
| 11:02 ET | 200 | 28.83 |
| 11:09 ET | 955 | 28.87 |
| 11:12 ET | 103 | 28.865 |
| 11:14 ET | 1900 | 28.81 |
| 11:18 ET | 225 | 28.79 |
| 11:20 ET | 5400 | 28.875 |
| 11:23 ET | 1500 | 28.895 |
| 11:25 ET | 2613 | 28.9 |
| 11:30 ET | 200 | 28.905 |
| 11:32 ET | 2400 | 29 |
| 11:34 ET | 100 | 28.98 |
| 11:38 ET | 804 | 28.88 |
| 11:41 ET | 400 | 28.75 |
| 11:43 ET | 210 | 28.8 |
| 11:45 ET | 100 | 28.75 |
| 11:48 ET | 503 | 28.885 |
| 12:01 ET | 100 | 28.945 |
| 12:03 ET | 100 | 28.89 |
| 12:08 ET | 700 | 28.85 |
| 12:10 ET | 3931 | 28.84 |
| 12:12 ET | 300 | 28.78 |
| 12:14 ET | 100 | 28.805 |
| 12:15 ET | 300 | 28.76 |
| 12:17 ET | 124 | 28.77 |
| 12:19 ET | 2912 | 28.9 |
| 12:26 ET | 100 | 28.89 |
| 12:32 ET | 500 | 28.875 |
| 12:33 ET | 718 | 28.8 |
| 12:37 ET | 100 | 28.81 |
| 12:39 ET | 201 | 28.81 |
| 12:42 ET | 100 | 28.81 |
| 12:46 ET | 3700 | 28.86 |
| 12:48 ET | 100 | 28.875 |
| 12:50 ET | 100 | 28.875 |
| 12:51 ET | 382 | 28.81 |
| 12:53 ET | 300 | 28.8275 |
| 12:57 ET | 300 | 28.76 |
| 01:02 ET | 100 | 28.81 |
| 01:04 ET | 200 | 28.81 |
| 01:08 ET | 1749 | 28.745 |
| 01:11 ET | 292 | 28.67 |
| 01:13 ET | 100 | 28.66 |
| 01:15 ET | 100 | 28.66 |
| 01:18 ET | 500 | 28.66 |
| 01:22 ET | 1329 | 28.545 |
| 01:24 ET | 931 | 28.6 |
| 01:26 ET | 740 | 28.56 |
| 01:27 ET | 300 | 28.53 |
| 01:29 ET | 257 | 28.52 |
| 01:31 ET | 200 | 28.52 |
| 01:33 ET | 200 | 28.48 |
| 01:36 ET | 100 | 28.42 |
| 01:38 ET | 1075 | 28.505 |
| 01:40 ET | 403 | 28.5 |
| 01:42 ET | 611 | 28.6099 |
| 01:44 ET | 200 | 28.555 |
| 01:47 ET | 200 | 28.555 |
| 01:49 ET | 200 | 28.555 |
| 01:51 ET | 500 | 28.63 |
| 01:54 ET | 100 | 28.64 |
| 01:56 ET | 300 | 28.64 |
| 01:58 ET | 200 | 28.64 |
| 02:00 ET | 600 | 28.69 |
| 02:03 ET | 200 | 28.63 |
| 02:05 ET | 100 | 28.69 |
Today
DJ Simulations Plus Initiated at Overweight by Stephens & Co., from 16 minutes ago by Dow Jones
16 minutes ago by Dow Jones
Nov 13, 2024
Nov 6, 2024
Simulations Plus to Participate in the Stephens Annual Investment Conference, from 8:30AM ET on Wednesday Nov 06, 2024 by Dow Jones
8:30AM ET on Wednesday Nov 06, 2024 by Dow Jones
Oct 30, 2024
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations, from 8:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
8:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 24, 2024
DJ Simulations Plus Is Maintained at Buy by BTIG, from 12:26PM ET on Thursday Oct 24, 2024 by Dow Jones
12:26PM ET on Thursday Oct 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Simulations Plus Inc | 596.2M | 58.6x | +0.62% |
Butterfly Network Inc | 545.4M | -5.0x | --- |
IRadimed Corp | 685.1M | 36.0x | +21.02% |
Standard BioTools Inc | 632.8M | -2.2x | --- |
Neuropace Inc | 288.9M | -8.6x | --- |
MaxCyte Inc | 362.9M | -10.2x | --- |
Company Information
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The Company’s comprehensive bio simulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. It operates through two segments: software and services. It offers software products for pharmaceutical research, development, and commercialization, including GastroPlus, DDDPlus, MembranePlus, ADMET Predictor, MedChem Designer, DILIsym, NAFLDsym, ILDsym, IPFsym and others. In addition, it also delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development.
Contact Information
- Headquarters
- 42505 10Th Street WestLANCASTER, CA, United States 93534-7059
- Phone
- 661-723-7723
- Fax
- 661-723-5524
Executives
- Chairman of the Board
- Walter Woltosz
- Chief Executive Officer
- Shawn O'Connor
- Chief Financial Officer, Chief Operating Officer, Secretary
- William Frederick
- President - PBPK, Regulatory Strategies, Cheminformatics Solutions
- John Dibella
- President - Clinical Pharmacology and Pharmacometric Services
- Jill Fiedler-Kelly
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $596.2M |
|---|---|
Revenue (TTM) | $70.0M |
Shares Outstanding | 20.1M |
Dividend Yield | 0.84% |
Annual Dividend Rate | 0.2400 USD |
Ex-Dividend Date | 07-29-24 |
Pay Date | 08-05-24 |
Beta | 0.73 |
EPS | $0.49 |
Book Value | $9.10 |
P/E Ratio | 58.6x |
Price/Sales (TTM) | 8.5 |
Price/Cash Flow (TTM) | 38.2x |
Operating Margin | 11.10% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
